BioNexus Gene Lab Corp. Long-term Purchase Commitment, Amount
BioNexus Gene Lab Corp. (BGLC) reported Long-term Purchase Commitment, Amount of $500.00 thousand for the 1-month period ending 2025-11-28, per its 10-K filed 2026-04-14.
Financial Statements › Notes › Commitment and Contingencies
us-gaap:LongTermPurchaseCommitmentAmount · last filed 2026-04-14
- 2025-11-28: Long-term Purchase Commitment, Amount 1 month $500.00K.
| Period end | Long-term Purchase Commitment, Amount 1 month |
|---|---|
| 2025-11-28 | $500.00K 10-K · filed 2026-04-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |